140 results
8-K
EX-99.1
TEVA
Teva- Pharmaceutical Industries Ltd.
8 May 24
Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook
7:01am
; disruptions of information technology systems; breaches of our data security; challenges associated with conducting business globally, including
8-K
EX-99.1
TEVA
Teva- Pharmaceutical Industries Ltd.
31 Jan 24
Results of Operations and Financial Condition
7:00am
in our supply chain or problems with internal or third party manufacturing; disruptions of information technology systems; breaches of our data security; challenges
8-K
EX-99.1
v476y2t zv
8 Nov 23
2023 revenues outlook revised to $15.1 - $15.5 billion from $15.0 - $15.4 billion
7:01am
8-K
EX-99.1
ek9k1eor iwz17z5h9
2 Aug 23
Results of Operations and Financial Condition
7:00am
8-K
EX-99.1
wkv5ku
10 May 23
Results of Operations and Financial Condition
7:01am
8-K
EX-99.1
2w5axe3
3 Nov 22
Key financial highlights and outlook
7:00am
8-K
EX-99.1
alxuhdlu4dwr1
26 Jul 22
Key financial highlights and outlook
4:56pm
8-K
EX-99.1
2p08z545c0dmsi7gli
3 May 22
Results of Operations and Financial Condition
7:01am
8-K
EX-99.1
f02kf5
9 Feb 22
Results of Operations and Financial Condition
7:00am
424B5
mhomvry
4 Nov 21
Prospectus supplement for primary offering
4:41pm
424B3
gdn35
27 Oct 21
Prospectus supplement
8:51am